Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Kbl Merger Corp IV Right (KBLMR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KBLMR with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1701 +130.45%
on 10/09/20
0.4101 -4.41%
on 11/06/20
+0.2020 (+106.32%)
since 10/06/20
3-Month
0.1623 +141.53%
on 08/10/20
0.4101 -4.41%
on 11/06/20
+0.2020 (+106.32%)
since 08/06/20
52-Week
0.0262 +1,396.18%
on 04/09/20
0.4101 -4.41%
on 11/06/20
+0.1820 (+86.67%)
since 11/06/19

Most Recent Stories

More News
KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020

KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC), today announced the successful completion of its acquisition of 180 Life Sciences Corp. ("180 Life Sciences"),...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020

KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180 Life Sciences Corp. ("180 Life Sciences"), today...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
Innovative Companies with Blockbuster Potential Catch SPAC Attention

NetworkNewsAudio - 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ:...

KBLMR : 0.3920 (+3.19%)
KBLM : 4.99 (-17.52%)
KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020

KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180 Life Sciences Corp. ("180 Life Sciences"), today...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
In Pursuit of the Elusive Drug -- the Billion-Dollar Blockbuster

, /PRNewswire/ -- Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery of a blockbuster...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
KBLMW : 0.1720 (-3.37%)
ALXN : 122.61 (+1.01%)
GILD : 59.89 (-0.37%)
LLY : 143.38 (-1.45%)
VRTX : 217.87 (+1.24%)
UPDATE -- The Quest for Blockbuster Drugs Continues

via NetworkNewsWire -- 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights...

KBLMR : 0.3920 (+3.19%)
KBLM : 4.99 (-17.52%)
Banking on the Next Blockbuster Drug

, /PRNewswire/ -- Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally...

KBLM : 4.99 (-17.52%)
KBLMR : 0.3920 (+3.19%)
KBLMW : 0.1720 (-3.37%)
JNJ : 143.87 (-1.70%)
ABBV : 102.18 (+1.33%)
AMGN : 222.22 (-0.43%)
NVS : 87.31 (-0.24%)
SPACs Surge as Biotech Booms

, /PRNewswire/ -- As the world has focused on the search for COVID vaccines and therapeutics, biotech IPOs have quietly . As a matter of fact, 2020 is on track to post the highest number of biotech IPOs...

KBLMR : 0.3920 (+3.19%)
RETA : 163.63 (+0.53%)
KBLM : 4.99 (-17.52%)
LLY : 143.38 (-1.45%)
MRK : 80.28 (-0.21%)
PANA : 10.21 (+1.09%)
Blockbuster Year and Bright Horizons for SPACs

, /PRNewswire/ -- The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over in proceeds — . A special purpose acquisition company (SPAC) is essentially a blank-check company...

KBLMR : 0.3920 (+3.19%)
IMVT : 49.38 (+2.13%)
KBLM : 4.99 (-17.52%)
IMTX : 10.69 (+1.81%)
AHCO : 29.22 (-2.54%)
CCXX : 9.84 (-4.00%)
KBL Merger Corp. IV Announces Special Meeting of Shareholders to be Held October 26, 2020 upon the SEC Declaring the S-4 Registration Statement Effective

KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced the acquisition of 180 Life Sciences Corp. ("180 Life Sciences"), today announced...

KBLMR : 0.3920 (+3.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar